RENEE PHAM: Open Payments
NPI 1003526187 · BREA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,073 in 46 payments from 19 companies in 2025. Trend: 2023 $150 · 2024 $522 · 2025 $1,073
Food & beverage: $1,073
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $206 |
| Lilly USA, LLC | 6 | $110 |
| Radius Health, Inc. | 3 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $70 |
| Novo Nordisk Inc | 2 | $62 |
| Insulet Corporation | 2 | $58 |
| Corcept Therapeutics | 2 | $57 |
| KYOWA KIRIN, INC. | 2 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
Products named: AIRSUPRA, JARDIANCE, Tymlos, Kerendia, Wegovy, Omnipod, Korlym, MOUNJARO.
Industry payments across CA — which companies pay providers there.
